Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on March 24, 2026

Mar. 24, 2026

Opus Genetics Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026

Indeterminate GlobeNewswire

Mar. 24, 2026

Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Mar. 24, 2026

CAMP4 Appoints Michael MacLean to its Board of Directors

Indeterminate GlobeNewswire

Mar. 24, 2026

Spectral Medical and Vantive Announce Publication of Complete Results from Spectral’s Tigris Trial in the Lancet Respiratory Medicine

Indeterminate GlobeNewswire

Mar. 24, 2026

Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Mar. 24, 2026

Outlook Therapeutics Announces Pricing of $5.0 Million Public Offering

Indeterminate GlobeNewswire

Mar. 24, 2026

Vireo Growth Inc. Announces Closing of Acquisition of Assets of Schwazze

Indeterminate GlobeNewswire

Mar. 24, 2026

Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance

Indeterminate GlobeNewswire

Mar. 24, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

Indeterminate GlobeNewswire

Mar. 24, 2026

Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting

Indeterminate GlobeNewswire

Mar. 24, 2026

BioNTech auf dem ELCC-Kongress 2026: Neue klinische Daten unterstreichen das Potenzial des differenzierten, spätklinischen Portfolios bei Lungenkrebs

Indeterminate GlobeNewswire

Mar. 24, 2026

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer

Indeterminate GlobeNewswire

Mar. 24, 2026

Compliance With Nasdaq Periodic Filing Requirement

Indeterminate GlobeNewswire

Mar. 24, 2026

iDEL Therapeutics Appoints Claudia Ulbrich as Chair of its Board of Directors

Indeterminate GlobeNewswire

Mar. 24, 2026

Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology

Indeterminate GlobeNewswire

Mar. 24, 2026

MINES and Associates COO Recognized as 2026 Colorado Titan 100 Recipient

Indeterminate GlobeNewswire

Mar. 24, 2026

Serina Therapeutics to Present at the 38th Annual Roth Conference

Indeterminate GlobeNewswire

Mar. 24, 2026

Zymeworks Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Mar. 24, 2026

Yatiri Bio Enters Exclusive Option to In-License Agreement with Oscotec for Denfivontinib in AML

Indeterminate GlobeNewswire

Mar. 24, 2026

AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst

Indeterminate GlobeNewswire